169 related articles for article (PubMed ID: 16780890)
1. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
J Neurol Sci; 2006 Oct; 248(1-2):48-52. PubMed ID: 16780890
[TBL] [Abstract][Full Text] [Related]
2. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Exp Neurol; 2004 Sep; 189(1):182-8. PubMed ID: 15296848
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Trevitt J; Kawa K; Jalali A; Larsen C
Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
[TBL] [Abstract][Full Text] [Related]
4. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
5. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
Carlson BB; Wisniecki A; Salamone JD
Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151
[TBL] [Abstract][Full Text] [Related]
6. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
7. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
[TBL] [Abstract][Full Text] [Related]
8. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
[TBL] [Abstract][Full Text] [Related]
9. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
Miwa H; Kubo T; Suzuki A; Kondo T
Parkinsonism Relat Disord; 2009 Jan; 15(1):30-5. PubMed ID: 18693129
[TBL] [Abstract][Full Text] [Related]
10. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
Salamone JD; Carlson BB; Rios C; Lentini E; Correa M; Wisniecki A; Betz A
Behav Brain Res; 2005 Jan; 156(2):173-9. PubMed ID: 15582103
[TBL] [Abstract][Full Text] [Related]
11. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
Tronci E; Simola N; Borsini F; Schintu N; Frau L; Carminati P; Morelli M
Eur J Pharmacol; 2007 Jul; 566(1-3):94-102. PubMed ID: 17445798
[TBL] [Abstract][Full Text] [Related]
13. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
Ishiwari K; Mingote S; Correa M; Trevitt JT; Carlson BB; Salamone JD
J Neurosci Methods; 2004 Dec; 140(1-2):39-46. PubMed ID: 15589332
[TBL] [Abstract][Full Text] [Related]
14. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Collins LE; Paul NE; Abbas SF; Leser CE; Podurgiel SJ; Galtieri DJ; Chrobak JJ; Baqi Y; Müller CE; Salamone JD
Pharmacol Biochem Behav; 2011 Sep; 99(3):414-22. PubMed ID: 21640750
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Pinna A; Pontis S; Borsini F; Morelli M
Synapse; 2007 Aug; 61(8):606-14. PubMed ID: 17476684
[TBL] [Abstract][Full Text] [Related]
16. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
[TBL] [Abstract][Full Text] [Related]
17. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
Ishiwari K; Betz A; Weber S; Felsted J; Salamone JD
Pharmacol Biochem Behav; 2005 Feb; 80(2):351-62. PubMed ID: 15680188
[TBL] [Abstract][Full Text] [Related]
18. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.
Mayorga AJ; Carriero DL; Cousins MS; Gianutsos G; Salamone JD
Pharmacol Biochem Behav; 1997 Feb; 56(2):273-9. PubMed ID: 9050085
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements.
Johnson JA; Montgomery AP; Starr ER; Ludwig J; Trevitt J
Eur J Pharmacol; 2018 Aug; 833():364-369. PubMed ID: 29883670
[TBL] [Abstract][Full Text] [Related]
20. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Wardas J; Konieczny J; Lorenc-Koci E
Synapse; 2001 Aug; 41(2):160-71. PubMed ID: 11400182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
